| (1) |
Saxena KM, Crawford JD, Talbot NB. 1964 Childhood thyrotoxicosis: a longer
term perspective. Br Med J. 2: 1153-1158. |
| (2) |
Bames HV, Blizzard RM. 1977 Antithyroid drug therapy for toxic diffuse
goiter (Graves disease): thirty years experience in children and adolescents.
J Pediatr. 91: 313-320. |
| (3) |
Fisher DA. 1994 Graves' disease in children. Curr Ther Endocrinol Metab.
5: 71-74. |
| (4) |
Zimmerman D, Lteif AN. 1998 Thyrotoxicosis in children. Endocrinol Metab
Clin North Am. 27: 109-125. |
| (5) |
Lippe BM, Landaw EM. Kaplan SA. 1987 Hyperthyroidism in children treated
with long term medical therapy: twenty-five percent remission every two
years. J Clin Endocrinol Metab. 64: 1241-1245. |
| (6) |
Hamburger JI. 1985 Management of hyperthyroidism in children and adolescents.
J Clin Endocrinol Metab. 60: 1019-1024. |
| (7) |
Cooper DS. 1991 Treatment of thyrotoxicosis. In: Braverman LE, Utiger
RD, eds. The thyroid: a fundamental and clinical text, 6th ed. Philadelphia:
Lippincott; 887-916. |
| (8) |
Crawford JD. 1981 Hyperthyroidism in children. A reevaluation of treatment.
Am J Dis Child. 135: 109-110. |
| (9) |
Foster RS, Jr. 1978 Morbidity and mortality after thyroidectomy. Surg
Gynecol Obstet. 146: 423-429. |
| (10) |
Levy WJ. Schumacher OP, Gupta M. 1988 Treatrnent of childhood Graves'
disease. A review with emphasis on radioiodine treatnent. Cleve Clin J Med.
55: 37-382. |
| (11) |
Crile Jr G, Skillem PG. 1968 Advantages of radioiodine over thyroidectomy
in the treatment of Graves' disease. Cleve Clin Q. 35: 73-77. |
| (12) |
Dobyns BM. 1973 Radioiodine vs. thyroidectomy for hyperthyroidism. Del
Med J. 45: 300-303. |
| (13) |
Farrar JJ, Toft AD. 1991 Iodine-131 treatment of hyperthyroidism: current
issues. Clin Endocrinol (Oxf) 35: 207-212. |
| (14) |
Foster Jr RS. 1975 Thyroid irradiation and carcinogenesis. Review with
assessment of clinical implications. Am J Surg. 130: 608-611. |
| (15) |
Freitas JE, Swanson DP, Gross MD, Sisson JC. 1979 Iodine-131: optimal
therapy for hyperthyroidism in children and adolescents? J Nucl Med. 20:
847-850. |
| (16) |
Hall P, Berg G, Bjelkengren G, et al. 1992 Cancer mortality after iodine-131
therapy for hyperthyroidism. Int J Cancer. 50: 886-890. |
| (17) |
Starr P, Jaffe HL, Oethnger Jr L. 1969 Later results of 131-1 treatment
of hyperthyroidism in 73 children and adolescents: 1967 followup. J Nucl
Med. 10: 586-590. |
| (18) |
Starr P, Jaffe HL, Oettinger LJ. 1964 Late results of 1311 treatment of
hyperthyroidism in 73 children and adolescents. J Nucl Med. 5: 81-89. |
| (19) |
Kogut MD, Kaplan SA, Collipp PJ, Tiamsic T, Boyle D. 1965 Treatment of
hyperthyroidism in chidlren: analysis of forty-five patients. N Engl J Med,
272: 217-222. |
| (20) |
Crile Jr G, Schumacher OP. 1965 Radioactive iodine treatment of Graves'
disease. Results in 32 children under 16 years of age. Am J Dis Child. 110:
501-504. |
| (21) |
Hayek A, Chapman EM, Crawford JD. 1970 Long-term results of treatment
of thyrotoxicosis in children and adolescents with radioactive iodine. N
Engl J Med. 283: 949 J953. |
| (22) |
Safa AM, Schumacher OP, Rodriguez-Antunez A. 1975 Long-term follow-up
results in children and adolescents treated with radioactive iodine (131-I)
for hyperthyroidism. N Engl J Med. 292: 167-171. |
| (23) |
Moll Jr GW, Patel BR. 1997 Pediatric Graves' disease: therapeutic options
and experience with radioiodine at the University of Mississippi Medical
Cen ter. South Med J. 90: l017-1022. |
| (24) |
Emerson CH, Braverman LE. 1980 Thyroid irradiation-one view. N Engi J
Med. 303: 217-219. |
| (25) |
Boice Jr JD. 1996 Cancer following irradiation in childhood and adolescence.
Med Pediatr Oncol, 1(Suppl): 29-34. |
| (26) |
Dolphin GW. 1968 The risk of thyroid cancers following irradiation. Health
Phys. 15: 219-228. |
| (27) |
Ron E, Lubin JH, Shore RE, et al. 1995 Thyroid cancer after exposure to
extemal radiation: a pooled analysis of seven studies. Radiat Res. 141 :
259-277. |
| (28) |
Shore RE. 1992 Issues and epidemiological evidence regarding radiationinduced
thyroid cancer. Radiat Res. 131: 98-111. |
| (29) |
Cooper DS. 1986 Which anti-thyroid drug? Am J Med. eo: 1165-1168. |
| (30) |
Cooper DS. 1984 Antithyroid drugs. N Engl J Med. 311: 1353-1362. |
| (31) |
Shiroozu A, Okamura K, Ikenoue H, et al. 1986 Treatment of hyperthyroidism
with a small single daily dose of methimazole. J Clin Endocrinol Metab.
63: 125-128. |
| (32) |
LeFranchi S, Mandel SH. 1991 Graves' disease in the neonatal period and
childhood. In: Braverman LE. Utiger RD, eds. The thyroid: a fundamental
and clinical text, 6th ed. Philadelphia: Lippincott; 1237-1246. |
| (33) |
Franklyn JA. 1994 The management of hyperthyroidism. N Engl J Med. 330:
1731-1738. |
| (34) |
Solomon BL. Evaul JE, Burman KD, Wartofsky L. 1987 Remission rates with
antithyroid drug therapy: continuing influence of iodine intake? Ann Intern
Med. 107: 510-512. |
| (35) |
Rittmaster RS, Abbott EC, Douglas R et al. 1998 Effects of methimazole,
with or without L-thyroxine, on remission rates in Graves' disease. J Clin
Endocrinol Metab. 83: 814-818. |
| (36) |
Hung W, Wilkins L, Blizzard RM. 1962 edical therapy of thyrotoxicosis
in children. Pediatrics. 30: 17-26. |
| (37) |
Vaidya VA, Bongiovanni AM. Parks JS, Tenore A, Kirkland RT. 1974 Twenty-two
years' experience in the medical management of juvenile thyrotoxicosis.
Pediatrics. 54: 565-570. |
| (38) |
Buckingham BA, Costin G, Roe TF, Weitzman JJ, Kogut MD. 1981 Hyperthyroidism
in children. A reevaluation of treatment. Am J Dis Child. 135: 112-117. |
| (39) |
Shulman DI, Muhar I. Jorgensen EV, Diamond FB, Bercu BB. Root AW. 1997
Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison
of clinical and biochemical features at diagnosis and responses to medical
therapy. Thyroid. 7: 755-760. |
| (40) |
Vitti P, Rago T, Chiovato L, et al. 1997 Clinical features of patients
with Graves' disease undergoing remission after antithyroid drug treatment.
Thyroid. 7: 369-375. |
| (41) |
Kim WB, Chung HK, Lee HK, Kohn LD, Tahara K, Cho BY. 1997 Changes in epitopes
for thyroid-stimulating antibodies in Graves' disease sera during treatment
of hyperthyroidism: therapeutic implications. J Clin Endocrinol Metab. 82:
1953-1959. |
| (42) |
Bouma DJ, Kammer H, Creer MA. 1982 Follow-up comparison of short-term
vs. 1-year antithyroid drug therapy for the thyrotoxicosis of Graves' disease.
J Clin Endocrinol Metab. 55: 1138-1142. |
| (43) |
Greer MA, Kammer H. Bouma DJ. 1977 Short-term antithyroid drug therapy
for the thyrotoxicosis of Graves's disease. N Engl J Med. 297: 173-176. |
| (44) |
Hayles AB, Zimmerman D. 1986 Grave's disease in childnood. In: Braverman
LE, Utiger RD, eds. The thyroid: a fundamental and clinical text, 5th ed.
Philadelphia: Lippincott; 1414-1423. |
| (45) |
Bartalena L, Bogazzi F, Manino E. 1996 Adverse effects of thyroid hormone
preparations and antithyroid drugs. Drug Safety. 15: 5Ch63. |
| (46) |
Amrhein JA, Kenny FM, R08s D. 1970 Granulocytopenia, iupus-like syndrome,
and other complications of propylthiouracil therapy. J Pediatr. 76: 54-63. |
| (47) |
Levy M. 1993 Propylthiouracil hepatotoxicity, A review and case presentation.
Clin Pediatr. 32: 25-29. |
| (48) |
Westphal SA. 1994 Hepatotoxicity from propylthiouracil. South Med J. 87:
943-947. |
| (49) |
Liaw YF, Huang MJ, Fan KD, Li KL. Wu SS, Chen TJ. 1993 Hepatic injury
during propylthiouracil therapy in patients with hyperthyroidism. A cohort
study. Ann Intern Med. 118: 424-428. |
| (50) |
Hanson JS. 1984 Propylthiouracil and hepatitis. Two cases and a review
of the literature. Arch Intern Med. 144: 994-996. |
| (51) |
Vasily DB, Tyler WB. 1980 Propylthiouracil-induced cutaneous vasculitis.
Case presentation and review of the literature. JAMA. 243: 458-461. |
| (52) |
Griswold WR, Mendoza SA, Johnston W. 1978 Vasculitis associated with propylthiouracil.
Evidence for irrunune complex pathogenesis and response to therapy. West
J Med. 128: 543-546. |
| (53) |
DHHS. 198S SEER cancer incidence and mortality in the United States, 1973-81.
DHus, NIH publication 85-1837. |
| (54) |
Belfiore A, Garofalo MR, Ciuffrida D, et al. 1990 Increased aggressiveness
of thyroid cancer in patients with Graves' disease. J Clin Endocrinol Metab.
70: 830-835. |
| (55) |
Mazzafeni EL. 1990 Thyroid cancer and Graves' disease. J Clin Endocrinol
Metab. 70: 826-829. |
| (56) |
Dobyns BM, Sheline CE, Worknan JB, Tompkins EA. McConahey WM, Becker DV.
1974 Malignant and benign neoplasms of the thyroid in patients treated for
hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up
study. J Clin Endocrinol Metab. 38: 976-998. |
| (57) |
Ching T, Warden MJ. Fefferman RA. 1977 Thyroid surgery in children and
teenagers. Arch Otolaryngol. 103: 544-546. |
| (58) |
Altman RP. 1973 Total thyroidectomy for the treatrnent of Graves' disease
in children. J Pediatr Surg. 8: 295-300. |
| (59) |
Miccoli P, Vitti P, RagQ T, et al. 1996 Surgical treatment of Graves'
disease: subtotal or total thyroidectomy? Surgery. 120: 1020-1024. |
| (60) |
Perzik SL. 1976 Total thyroidectomy in Graves' disease in children. J
Pediatr Surg. 11: 191-194. |
| (61) |
Rudberg C, Johansson H, Akerstrom C, Tuvemo T, Karlsson FA. 1996 Graves'
disease in children and adolescents. Late results of surgical treatment.
Eur J Endocrinol. 134: 710-715. |
| (62) |
Thompson NW. Dunn EL, Freitas JE, Sisson JC. Coran AG, Nishiyama RH. 1977
Surgical treatment of thyrotoxicosis in children and adolescents. J Pediatr
Surg. 12: 1009-1018. |
| (63) |
Argov S, Duek D. 1982 The vanishing surgical treatment of Graves' disease:
review df current literature and experience with 50 patients. Curr Surg.
39: 158-162. |
| (64) |
Becker DV, Sawin cr. 1996 Radioiodine and thyroid disease: the beginning.
Semin Nucl Med. 26: 155-164. |
| (65) |
Chapman EM. 1983 History of the discovery and early use of radioactive
iodine. JAMA. 250: 2042-204. |
| (66) |
Links JM, Wagner HN. 1995 Radiation physics. In: Braverman LE, Utiger
RD, eds. The thyroid: a fundamental and clinical text, 6th ed. Philadelphia:
Lippincott; 405-420. |
| (67) |
Williams ED. 1995 Biological effects of radiation on the thyroid. In:
Braverman LE. Utiger RD, eds. The thyroid: a fundamental and clinical text,
6th ed. Philadelphia: Lippincott; 421-436. |
| (68) |
Cunnien AJ, Hay ID, Gorman CA, Offord KP, Scanlon PW. 1982 Radioiodine-induced
hypothyroidism in Graves' disease: factors associated. J Nucl Med. 23: 978-983. |
| (69) |
de Bruin TW, Croon CD, de Klerk JM, van Isselt JW. 1994 Standardized radioiodine
therapy in Graves' disease: the persistent effect of thyroid weight and
radioiodine uptake on outcome. J Intem Med. 236: 507-513. |
| (70) |
Dobyns BM. 1975 Radiation effects of radiodine on the thyroid. Effects
vary with dosage and sensitivity of the gland to radiation. RI Med J. 58:
122-125. |
| (71) |
Vitti P, Martino E, Aghini-Lombardi F, et al. 1994 Thyroid volume measurement
by ultrasound in children as a tool for the assessment of mild iodine deficiency.
J Clin Endocrinol Metab. 79: 600-603. |
| (72) |
Ueda D. 1990 Normal volume of the thyroid gland in children. J Clin Ultrasound.
18: 455-462. |
| (73) |
Ueda D. 1989 Sonographic measurement of the volume of the thyroid gland
in healthy children. Acta Paediatr Jpn. 31: 352-354. |
| (74) |
Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. 1995 Radioiodine
therapy of Graves' hyperthyroidism: standard vs. calculated 13liodine activity.
Results from a prospective, randomized. multicentre study. Eur J Clin Invest.
25: 186-193. |
| (75) |
Maxon HR, Thomas SR, Hertzberg VS, et al. 1983 Relation between effective
radiation dose and outcome of radioiodine therapy for thyroid cancer. N
Engl J Med. 309: 937-941. |
| (76) |
Goolden AWC, Davey JB. 1963 The ablation of normal thryoid tissue with
iodine-131. Br J Radiol. 36: 340-345. |
| (77) |
Graham GD, Bunnan KD. 1986 Radioiodine treatment of Graves' disease. An
assessment of its potential risks. Ann Intern Med. 105: 900-905. |
| (78) |
Becker DV, Hurley JR. 1971 Complications of radioiodine treatment of hyperthyroidism.
Sentin Nucl Med. 1: 442-460. |
| (79) |
Refetoff S, Demeester-Mirkine N, Ermans AM, DeGroot LJ. 1977 Rapid control
of thyrotoxicosis with combined 1311, anthithyroid drugs and KI therapy.
J Nucl Med Allied Sci. 21: 23-29. |
| (80) |
Ross DS,Daniels GH, De Stefano P, Maloof F, Ridgway EC. 1983 Use of adjunctive
potassium iodide after after radioioactive iodine(131-I) treatment of Graves'
hyperthyroidism. J Clin Endocrinol Metab. 57: 250-253. |
| (81) |
Aizawa Y, Yoshida K, Kaise N, et al. 1997 The development of transient
hypothyroidism after iodine-131 treatment in hyperthyroid patients with
Graves' disease: prevalence, mechanism and prognosis. Clin Endocrinol (Oxf)
46: 1-5. |
| (82) |
Goolden AW. Stewart JS. 1986 Long-term results from graded low dose radioactive
iodine therapy for thyrotoxicosis. Clin Endocrinol (Oxf) 24: 217-222. |
| (83) |
McCullagh EP, Jelden GL, Rodriguez-Antunez A. 1976 Incidence of hypothyroidism
following small doses of 131-I in the treatment of Graves' disease. Ohio
State Med J. 72: 538-540. |
| (84) |
Rapoport B, Caplan R, DeCroot LJ. 1973 Low-dose sodium iodide l31-I therapy
in Graves disease. JAMA. 224: 1610-1613. |
| (85) |
Sridama V, McConnick M, Kaplan EL, Fauchet R, DeCroot LJ. 1984 Longterm
follow-up study of compensated low-dose 131-1 therapy for Graves' disease.
N Engl J Med. 311: 426-432. |
| (86) |
Sridama V, DeGroot LJ. 1989 Treatment of Graves' disease and the course
of ophthalmopathy. Am J Med. 87: 70-73. |
| (87) |
Safa AM, Skillern PG. 1975 Treatment of hyperthyroidism with a large initial
dose of sodium iodide l31-I. Arch Intern Med. 135: 673-675. |
| (88) |
Sheline GE, Lindsay S, McCormack KR, Galante M. 1962 Thyroid nodules occuring
late after treatment of thyrotoxicosis with radioiodine. J Clin Endocrinol
Metab. 22: 8-17. |
| (89) |
Snyder S. 1978 Vocal cord paralysis after radioiodine therapy. J Nucl
Med. 19: 975-976. |
| (90) |
Chiovato L, Fiore E, Vitti P, et al. 1998 Outcome of thyroid function
in Graves' patients treated with radioiodine: role of thyroid-stimulating
and thyrotropin-blocking antibodies and of radioiodine-induced thryoid damage.
J Clin Endocrinol Metab. 83: 40-46. |
| (91) |
Peters H, Fischer C, Bogner U. Reiners C, Schleusener H. 1997 Treatment
of Graves' hyperthyroidism with radioiodine: results of a prospective randomized
study. Thyroid. 7: 247-251. |
| (92) |
Murakami Y. Takalnatsu J, Sakane S. Kuma K, Ohsawa N. 1996 Changes in
thyroid volume in response to radioactive iodine for Graves' hyperthyroidism
correlated with activity of thyroid-stirnulating antibody and treatment
outcome. J Clin Endocrinol Metab. 81: 3257-3260. |
| (93) |
Hancock LD, Tuttle RM, LeMar H, Bauman J, Patience T. 1997 The effect
of propylthiouracil on subsequent radioactive iod ine therapy in Graves'
disease. Clin Endocrinol (Oxf) 47: 425-430. |
| (94) |
Tuttle RM, Patience T, Budd S. 1995 Treatment with propylthiouracil before
radioactive iodine therapy is associated with a higher treatment failure
rate than therapy with radioactive iodine alone in Graves' disease. Thyroid.
5: 243-247. |
| (95) |
Yoshida K, Aizawa Y, Kaise N, et al. 1996 Relationship between thyroidstitnulating
antibodies and thyrotropin-binding inhibitory irnmunoglobulins years after
administration of radioiodine for Graves' disease: retrospective clinical
survey. J Endocrinol Invest. 19: 682-686. |
| (96) |
Goolden AW, Kam KC, Fitzpatrick ML, Munro AJ. 1986 Oedema of the neck
after ablation of the thyroid with radioactive iodine. Br J Radiol. 59:
583-586. |
| (97) |
Craswell PW. 1972 Vocal cord paresis following radioactive iodine therapy.
Br J Clin Pract. 26: 571-572. |
| (98) |
Benua RS, Becker DV, Hurley JR. 1994 Thyroid storm. Curr Ther Endocrinol
Metab. 5: 75-7. |
| (99) |
Creutzig H, Kallfelz I, Haindl J, Thiede G, Hundeshagen H. 1976 Thyroid
storm and iodine-l31 treatrnent [Letter]. Lancet. 2: 145. |
| (100) |
DeGroot LJ, Gorman CA, Pinchera A, et al. 1995 Therapeutic controversies.
Retro-orbital radiation and radioactive iodide ablation of the thyroid may
be good for Graves' ophthalmopathy. J Clin Endocrinol Metab. 80: 339-34O. |
| (101) |
Tallstedt L, Lundell G. 1997 Radioiodine treatment, ablation, and ophthalmopathy:
a balanced perspective. Thyroid. 7: 241-245. |
| (102) |
Bartley GB, Fatourechi V. Kadrmas EF. et al. 1996 Chronology of Graves'
ophthalmopathy in an incidence cohort. Am J Ophthalmol. 121: 426-434. |
| (103) |
Femandez Sanchez JR. Rosell Pradas J, Carazo Martinez O, et al, 1993 Graves'
ophthalmopathy after subtotal thyroidectomy and radioiodine therapy. Br
J Surg. 80: 1134-1136. |
| (104) |
Gorman CA. 1995 Therapeutic controversies. Radioiodine therapy does not
aggravate Graves' ophthalmopathy. J Clin Endocrinol Metab. 80: 340-342. |
| (105) |
Cwinup G, Elias AN, Ascher MS. 1982 Effect on exophthalmos of various
methods of treatment of Graves' disease. JAMA. 247: 2135-2138. |
| (106) |
Wartofsky L. 1997 Radioiodine therapy for Graves' disease: case selection
and restrictions recommended to patients in North America. Thyroid. 7: 213-216. |
| (107) |
Bartalena L, Marcocci C, Bagozzi F, et al. 1998 Relation between therapy
for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med.
338: 73-78. |
| (108) |
Wiersinga WM. 1998 Preventing Graves' ophthalmopathy. N Engl J Med. 338:
121-122. |
| (109) |
Barth A, Probst P, Burgi H. 1991 Identification of a subgroup of Graves'
disease patients at hig. her risk for severe ophthalmopathy after radioiodine.
J Endocrinol Invest. 14: 209-212. |
| (110) |
Bondeson AG, Bondeson L, Thompson NW. 1989 Hyperparathyroidism after treatment
with radioactive iodine: not only a coincidence? Surgery. 106: 1025-1027. |
| (111) |
Fulop M. 1971 Hypoparathyroidism after 131-I therapy. Ann Intern Med.
75: 808. |
| (112) |
Orme MC, Conolly ME. 1971 Hypoparathyroidism after iodine-131 treatment
of thyrotoxicosis. Ann Intern Med. 75: 136-137. |
| (113) |
Burch WM, Posillico JT. 1983 Hypoparathyroidism after 1-131 therapy with
subsequent return of parathyroid function. J Clin Endocrinol Metab. 57:
398-401 . |
| (114) |
Schneider AB, Gierlowski TC, Shore-Freedman E, Stovall M, Ron E, Lubin
J. 1995 Dose-response relationships for radiation-induced hyperparathyroidism.
J Clin Endocrinol Metab. 80: 254-257. |
| (115) |
Fujiwara S, Sposto R, Ezaki H, et al. 1992 Hyperparathyroidism among atornic
bomb survivors in Hiroshima. Radiat Res. 130: 372-378. |
| (116) |
Esselstyn Jr CB, Schumacher OP. Eversman J, Sheeler L, Levy WJ. 1982 Hyperparathyroidism
after radioactive iodine therapy for Graves disease. Surgery. 92: 811-813. |
| (117) |
Fjalling M, Dackenberg A, Hedman I, Tisell LE. 1983 An evaluation of the
risk of developing hyperparathyroidism after 1311 treatment for thyrotoxicosis.
Acta Chir Scand. 149: 681-686. |
| (118) |
Duffy Jr BJ. Fitzgerald PJ. 1950 Cancer of the thyroid in children: a
report of twenty-eight cases. J Clin Endocrinol Metab. 10: 1296-1308. |
| (119) |
Hall P. Holm LE, Lundell G, et al. 1991 Cancer risks in thyroid cancer
patients. Br J Cancer. 64: 159-163. |
| (120) |
Holm LE, Hall P, Wiklund K, et al. 1991 Cancer risk after iodine-131 therapy
for hypenhyroidism. J Natl Cancer Inst. 83: 1072-1077. |
| (121) |
Pochin EE. 1968 Leukemia following radioiodine treatment of thyrotoxicosis.
Br Med J. 11: 1545-1550. |
| (122) |
Wemer SC, Gittleshon AM, Brill AB. 1961 Leukemia following radioiodine
therapy of hyperthyroidism. JAMA. 177: 646-648. |
| (123) |
Becker DV. Robbins J, Beebe GW. Bouville AC, Wachholz BW. 1996 Childhood
thyroid cancer following the Chemobyl accident: a status report. Endocrinol
Metab Clin North Am. 25: 197-211. |
| (124) |
Goldman MB, Monson RR, Maloof F. 1990 Cancer mortality in women with thyroid
disease. Cancer Res. 50: 2283-2289. |
| (125) |
Ron E. Saftlas AF. 1996 Head and neck radiation carcinogenesis: epidemiologic
evidence. Otolaryngol Head Neck Surg. 115: 403-408. |
| (126) |
Thompson DE. Mabuchi K, Ron E. et al. 1994 Cancer incidence in atomic
bomb survivors. II. Solid tumors, 1958-1987. Radiat Res. 137: 517-S67. |
| (127) |
Boice Jr JD. 1998 Radiation and thyroid cancer-what more can be leamed?
Acta Oncol. 34: 321-324. |
| (128) |
Tucker MA, Jones PH, Boice Jr JD. 1991 Therapeutic radiation at a young
age is linked to secondary thyroid cancer. The Late Effects Study Group.
Cancer Res. 51: 2885-2888. |
| (129) |
Hall P, Mattsson A, Boice Jr JD. 1996 Thyroid cancer after diagnostic
administration of iodine-131. Radiat Res. 145: 86-92. |
| (130) |
Hall P, Furst CJ, Mattsson A, Holm LE, Boice Jr JD, Inskip PD. 1996 Thyroid
nodularity after diagnostic administration of iodine-131. Radiat Res. 146:
673-682. |
| (131) |
Holm LE. 1980 Thyroid treatment and its possible influence on occurrence
of malignant tumors after diagnostic 1311. Acta Radiol Oncol. 19: 455-459. |
| (132) |
Holm LE. Eklund C, Lundell G. 1980 Incidence of malignant thyroid tumors
in humans after exposure to diagnostic doses of iodine-131. ll. Estimation
of thyroid gland size, thyroid radiation dose, and predicted vs. observed
number of malignant thyroid tumors. J Natl Cancer Inst. 65: 1221-1224. |
| (133) |
Wang ZY. Boice Jr JD, Wei LX. et al. 1990 Thyroid nodularity and chromosome
aberrations among women in areas of high background radiation in China.
J Natl Cancer Inst. 82: 478-485. |
| (134) |
Conard RA, Dobyns BM, Sutow wrV. 1970 Thyroid neoplasia as late effect
of exposure to radioactive iodine in fallout. JAMA. 214: 316-324. |
| (135) |
Baverstock K. Egloff B, Pinchera A, Ruchti C, Williams D. 1992 Thyroid
cancer after Chernobyl. Nature. 359: 21-22. |
| (136) |
Kazakov VS, Demidchik EP, Astakhova LN. 1992 Thyroid cancer after Chemobyl.
Nature. 359: 21. |
| (137) |
Robbins J. Schneider AB. 1998 Radioiodine-induced thyroid cancer-studies
in the aftermath of the accicent at Chemobyl. Trends Endocrinol Metab. 9:
87-94. |
| (138) |
Nikiforov Y, Gnepp DR, Fagin JA. 1996 Thyroid lesions in children and
adolescents after the Chernobyl disaster: implications for the study of
radiation tumorigenesis. J Clin Endocrinol Metab. 81: 9-14. |
| (139) |
Nikiforov YE, Heffess CS, Korzenko AV, Fagin JA, Gnepp DR. 1995 Characteristics
of follicular tumors and nouneoplastic thyroid lesions in children and adolescents
exposed to radiation as a result of the Chemobyl disaster. Cancer. 76: 900-909. |
| (140) |
Holm LE, Dahlqvist I, Israelsson A, Lundell G. 1980 Malignant thyroid
tumors after iodine-131 therapy: a retrospective cohort study. N Engl J
Med. 303: 188-191. |
| (141) |
Hall P, Boice Jr JD. Berg G. et al. 1992 Leukaemia incidence after iodine-131
exposure. Lancet. 340: 1-4. |
| (142) |
Munoz JM. Gonnan CA, Elveback LR, Wentz JR. 1978 Incidence of malignant
neoplasms of all types of patients with Graves' disease. Arch Intern Med.
138: 944-947. |
| (143) |
Goldman MB, Maloof F, Monson RR, Aschengrau A, Cooper DS. Ridgway EC.
1988 Radioactive iodine therapy and breast cancer. A follow-up study of
hyperthyroid women. Am J Epidemiol. 127: 969-980. |
| (144) |
Hoffman DA, McConahey WM. 1983 Breast cancer following iodine-131 therapy
for hyperthyroidism. J Natl Cancer Inst. 70: 63-67. |
| (145) |
Kumpusalo L, Kumpusalo E, Soimakallio S, et al. 1996 Thyroid ultrasound
findings 7 years after the Chemobyl accident. A comparative epidemiologjcal
study in the Bryansk region of Russia. Acta Radiol. 37: 904-909. |
| (146) |
Farbota LM, Calandra DB, Lawrence AM, Paloyan E. 1985 Thyroid carcinoma
in Graves' disease. Surgery. 98: 1148-1153. |
| (147) |
Karlan MS, Pollock WF, Snyder WH. 1964 Cardnoma of the thyroid following
treatment of hyperthyroidism with radioactive iodine. Califomia Med J. 101:
196-201. |
| (148) |
Gorman CA, Robertson JS. 1978 Radiation dose in the selection of 131-1
or surgical treatrnent for toxic thyroid adenoma. j~n Intern Med. 89: 85-90. |
| (149) |
Utiger RD. 1992 Pathogenesis of Graves' ophthalmopathy. N Engl J Med.
326: 1772-1773. |
| (150) |
Land CE. 1980 Estimating cancer risks from low doses of ionizing radiation.
Science. 209: 1197-1203. |
| (151) |
Robertson JS, Gonnan CA. 1976 Gonadal radiation dose and its genetic significance
in radioiodine therapy of hyperthyroidism. J Nucl Med, 17: 826-835. |
| (152) |
Sarkar SD, Beierwaltes WH, Gill SP, Cowley BJ. 1976 Subsequent fertility
and birth histories of children and adolescents treated with 131-1 for thyroid
cancer. J Nucl Med. 17: 460-464. |
| (153) |
Schull WJ, Otake M, Neel JV. 1981 Genetic effects of the atomic bombs:
a reappraisal. Science. 213: 1220-1227. |
| (154) |
McDougall IR, Nelsen TS, Kempson RL. 1981 Papillary carcinoma of the thyroid
seven years after I-131 therapy for Graves' disease. Clin Nucl Med. 6: 368-371
. |
| (155) |
Zimmerman D, Hay ID, Gough IR, et al. 1988 Papillary thyroid carcinoma
in children and adults: Iong-term follow-up of 1039 patients conservatively
treated at one institution during three decades. Surgery. 104: 1157-1166. |
| (156) |
Ain KB. 1995 Papillary thyroid carcinoma. Etiology, assessment. and therapy.
Endocrinol Metab Clin North Am. 24: 711-760. |
| (157) |
Moir CR, Telander RL. 1994 Papillary carcinoma of the thyroid in children.
Semin Pediatr Surg. 3: 182-187. |
| (158) |
Spencer RP, Kayani N, Karimeddini MK. 1985 Radioiodine therapy of hyperthyroidism:
socioeconomic considerations. J Nucl Med. 26: 663-665. |
| (159) |
Ron E, Doody MM, Becker DV, et al. 1998 Cancer mortality following treatment
for adult hyperthyroidism. JAMA. 280: 347-355. |